352 related articles for article (PubMed ID: 30097704)
21. Update on surgical treatment of pancreatic neuroendocrine neoplasms.
D'Haese JG; Tosolini C; Ceyhan GO; Kong B; Esposito I; Michalski CW; Kleeff J
World J Gastroenterol; 2014 Oct; 20(38):13893-8. PubMed ID: 25320524
[TBL] [Abstract][Full Text] [Related]
22. Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms-A Single-Center Retrospective Outcome Analysis.
Lindner K; Binte D; Hoeppner J; Wellner UF; Schulte DM; Schmid SM; Luley K; Buchmann I; Tharun L; Keck T; Gebauer J; Kulemann B
Curr Oncol; 2021 Aug; 28(4):3071-3080. PubMed ID: 34436034
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
[TBL] [Abstract][Full Text] [Related]
24. [Surgical treatment for pancreatic neuroendocrine neoplasmas].
Wu J; Guo F; Wei J; Lu Z; Chen J; Gao W; Li Q; Jiang K; Dai C; Miao Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):31-5. PubMed ID: 27045238
[TBL] [Abstract][Full Text] [Related]
25. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
26. Resection strategies for neuroendocrine pancreatic neoplasms.
Watzka FM; Laumen C; Fottner C; Weber MM; Schad A; Lang H; Musholt TJ
Langenbecks Arch Surg; 2013 Mar; 398(3):431-40. PubMed ID: 23143147
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic radical 'no-touch' left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results.
Abu Hilal M; Richardson JR; de Rooij T; Dimovska E; Al-Saati H; Besselink MG
Surg Endosc; 2016 Sep; 30(9):3830-8. PubMed ID: 26675941
[TBL] [Abstract][Full Text] [Related]
28. [Surgical strategies for small sporadic neuroendocrine pancreatic tumors].
Holzer K
Chirurg; 2018 Jun; 89(6):422-427. PubMed ID: 29637243
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
[TBL] [Abstract][Full Text] [Related]
30. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case.
Usui M; Kuriyama N; Uchida K; Kishiwada M; Mizuno S; Sakurai H; Tabata M; Shiraishi T; Isaji S
Asian J Endosc Surg; 2014 Aug; 7(3):271-4. PubMed ID: 25131327
[TBL] [Abstract][Full Text] [Related]
32. Surgical Management of Pancreatic Neuroendocrine Tumors.
Vaghaiwalla T; Keutgen XM
Surg Oncol Clin N Am; 2020 Apr; 29(2):243-252. PubMed ID: 32151358
[TBL] [Abstract][Full Text] [Related]
33. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
Brunner SM; Weber F; Werner JM; Agha A; Farkas SA; Schlitt HJ; Hornung M
BMC Surg; 2015 Apr; 15():49. PubMed ID: 25928025
[TBL] [Abstract][Full Text] [Related]
36. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
37. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.
DiNorcia J; Lee MK; Reavey PL; Genkinger JM; Lee JA; Schrope BA; Chabot JA; Allendorf JD
J Gastrointest Surg; 2010 Oct; 14(10):1536-46. PubMed ID: 20824378
[TBL] [Abstract][Full Text] [Related]
38. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
[TBL] [Abstract][Full Text] [Related]
39. The role of laparoscopic distal pancreatectomy in elderly patients.
Giuliani A; Ceccarelli G; Rocca A
Minerva Chir; 2018 Apr; 73(2):179-187. PubMed ID: 29366312
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
